Stockscreener 앱 받기
1.7999
2.21%
-0.0301
전일 마감가:
$1.83
열려 있는:
$1.8
하루 거래량:
60,646
Relative Volume:
0.23
시가총액:
$49.65M
수익:
$80.97M
순이익/손실:
$-78.31M
주가수익비율:
-0.1624
EPS:
-11.0849
순현금흐름:
$-129.56M
1주 성능:
+6.52%
1개월 성능:
+17.73%
6개월 성능:
+1.39%
1년 성능:
+2.26%
1일 변동 폭
$1.7506
$1.82
1주일 범위
$1.68
$1.8598
52주 변동 폭
$1.325
$2.89
Fortress Biotech Inc Stock (FBIO) Company Profile
명칭
Fortress Biotech Inc
전화
781-652-4500
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
FBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.7999 | 49.65M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.17 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.85 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
657.08 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.26 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.95 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-15 | 재개 | ROTH MKM | Buy |
| 2022-08-04 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-02 | 개시 | The Benchmark Company | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2018-02-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
| 2017-03-22 | 개시 | JMP Securities | Mkt Outperform |
| 2016-10-03 | 개시 | ROTH Capital | Buy |
모두보기
Fortress Biotech Inc 주식(FBIO)의 최신 뉴스
Renaissance Technologies LLC Has $356,000 Stock Holdings in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Fortress Biotech, Inc. (NASDAQ:FBIO) Stock Position Boosted by Envestnet Asset Management Inc. - Defense World
Geode Capital Management LLC Increases Stock Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - The Globe and Mail
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - ADVFN
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
Fortress Biotech Board Member Resigns for New Role - TipRanks
When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com
Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World
This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance
Roth Capital Forecasts Reduced Earnings for Fortress Biotech - Defense World
FBIO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Tuesday Deadline in Securities Class ActionFBIO - MarketScreener
SEC Form POS AM filed by Fortress Biotech Inc. - Quantisnow
Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Fortress Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Fortress Biotech’s Mixed Earnings Call: Emrosi’s Launch and Challenges - TipRanks
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
MUSTANG BIO, INC. SEC 10-K Report - TradingView
Journey Medical Reports 2024 Financial Results - TipRanks
FDA Green Light for Journey Medical's Rosacea Drug Reshapes 2024 Performance - StockTitan
Fortress Biotech Inc (FBIO) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Fortress Biotech (NASDAQ:FBIOP) Trading Up 3.9% – Here’s Why - Defense World
Fortress Biotech (FBIO) Expected to Announce Earnings on Thursday - Defense World
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewswire
Journey Medical Sets Date for 2024 Annual Results: Dermatology Leader's Financial Update - Stock Titan
Atria Investments Inc Buys 16,841 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Partex And Fortress Biotech Announce Collaboration To Accelerate Biopharma Asset Evaluation - Nasdaq
Fortress Biotech, Partex Team Up for Asset Identification, Evaluation Using AI -March 17, 2025 at 09:36 am EDT - Marketscreener.com
Fortress Biotech partners with Partex for AI-driven drug discovery By Investing.com - Investing.com Australia
Fortress Biotech partners with Partex for AI-driven drug discovery - Investing.com
Partex NV and Fortress Biotech, Inc. Announce Strategic Collaboration to Leverage AI in Biopharmaceutical Drug Discovery - Nasdaq
Partex and Fortress Biotech Announce Strategic - GlobeNewswire
AI Breakthrough: Fortress Biotech's New Partnership Transforms Drug Development Process - StockTitan
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Equities Analysts Offer Predictions for FBIO Q1 Earnings - Defense World
Fortress Biotech (NASDAQ:FBIO) Receives “Buy” Rating from Roth Mkm - Defense World
Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest
Benign Growth For Fortress Biotech, Inc. (NASDAQ:FBIO) Underpins Its Share Price - Simply Wall St
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Lake Street Downgrades Checkpoint Therapeutics to Hold From Buy, $4.10 Price Target - Marketscreener.com
Checkpoint (CKPT) Shares Skyrocket After A Takeover Agreement - Stocks Telegraph
Checkpoint Therapeutics Shares Leap Premarket on Takeover by Sun Pharma -March 10, 2025 at 06:24 am EDT - Marketscreener.com
Sun Pharma Pays 66% Premium in $355M Checkpoint Therapeutics Acquisition - Stock Titan
Checkpoint Therapeutics to Be Acquired by India's Sun Pharmaceutical -March 10, 2025 at 04:50 am EDT - Marketscreener.com
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher - Mint
Sun Pharma to acquire Checkpoint Therapeutics for $355 million - Fortune India
Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn - Business Standard
Sun Pharma to acquire 100% stake in Nasdaq-listed Checkpoint Therapeutics - Business Standard
Fortress Biotech Inc (FBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fortress Biotech Inc 주식 (FBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 11 '24 |
Buy |
7.48 |
5,000 |
37,418 |
127,500 |
| Jin David | Chief Financial Officer |
Jul 10 '24 |
Buy |
7.50 |
500 |
3,750 |
500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 09 '24 |
Buy |
7.39 |
5,000 |
36,971 |
122,500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jul 08 '24 |
Buy |
7.35 |
5,000 |
36,764 |
117,500 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
Jun 28 '24 |
Buy |
1.64 |
20,000 |
32,724 |
2,893,905 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman |
May 16 '24 |
Buy |
1.76 |
10,000 |
17,589 |
2,873,905 |
| Klein Dov | Director |
May 20 '24 |
Sale |
1.89 |
10,000 |
18,900 |
53,400 |
0.52%
0.52%
자본화:
|
볼륨(24시간):